ARCHIVES

FDA Issues Final Rules On Patient Access To Investigational Drugs

This article is from The Cancer Letter archive.

Vol. 35 No. 33 | September 11, 2009

Download PDF Visit The Full Archive

Related Articles

HRSA: Discounts Owed on Some Orphan Drug Uses

October 24, 2014

In Brief: Berlin Leaving Northwestern To Become Zubrod’s Deputy at Miami; Four Center Director Jobs Open

August 7, 1987

ACS, SU2C Committ $20 Million For Lung Cancer Dream Team

January 31, 2014

In Brief: Voters Support Increase In Research Funds, Poll Finds; Baynes Heads BMT Unit In Detroit

February 28, 1997

Longer List of DCPC Spending Plans $40 Mll Increase

December 10, 1993

Cancer research poised for a “platinum age” as a “golden age” ends, NCI director tells AACR annual meeting.

April 29, 2005